** Flutiform® (fluticasone propionate/ formoterol fumarate dihydrate) 250 microgram/10 microgram per actuation – presurrised inhalation, suspension. 120 actuations for inhalation use.
** Flutiform® should NOT be used in children less than 18 years of age.
** Composition:
Each metered dose (ex-valve) contains:
250 micrograms of fluticasone propionate and 10 micrograms of formoterol fumarate dihydrate.
This is equivalent to a delivered dose (ex-actuator) of approximately 230 micrograms of fluticasone propionate and 9.0 micrograms of formoterol fumarate dihydrate.
Also contains: sodium cromoglicate, ethanol anhydrous and apaflurane HFA 227.
** Read the package leaflet carefully before use.
Full instructions for use can be found in the package leaflet.
Use as directed by your doctor or pharmacist.
Shake well before use.
Use within 3 months of opening the foil pouch.
Use regularly.
** Do not store above 30 degrees C or in direct sunlight, Do not freeze.
The canister contains a pressurised liquid.
Do not expose to temperatures higher than 50 degrees C.
Do not puncture, break or burn even when apparently empty.
Keep out of reach and sight of children.
** Manufactured by:
Fisons Limited
London road, Holmes Chapel, Crewe, Cheshire CW48BE, United kingdom
Marketing Authorisation Holder:
Napp Pharmaceuticals Ltd. (I.A.C of Mundipharma)
Cambridge Science Park, Milton Road, Cambridge, CB4 0GW United Kingdom
Mohamed El Ghandour –